We are live on ! Find out more
NBG

Nancy B. Gardiner Portfolio holdings

AUM $60.4M
1-Year Est. Return 13.19%
This Fund
S&P 500
This Quarter Est. Return
+0.85%
1 Year Est. Return
+13.19%
3 Year Est. Return
+51.16%
5 Year Est. Return
10 Year Est. Return
AUM
$58.9M
AUM Growth
-$2.33M
Cap. Flow
-$2.49M
Cap. Flow %
-4.23%
Top 10 Hldgs %
33.67%
Holding
71
New
1
Increased
13
Reduced
34
Closed
4

Top Buys

Rank Stock Value
1
BDX icon
Becton Dickinson
BDX
+$347K
2
ILMN icon
Illumina
ILMN
+$204K
3
ORA icon
Ormat Technologies
ORA
+$196K
4
TJX icon
TJX Companies
TJX
+$113K
5
MSFT icon
Microsoft
MSFT
+$98.7K

Top Sells

Rank Stock Value
1
ENTA icon
Enanta Pharmaceuticals
ENTA
+$1.41M
2
EOG icon
EOG Resources
EOG
+$254K
3
ORCL icon
Oracle
ORCL
+$242K
4
IPGP icon
IPG Photonics
IPGP
+$220K
5
MA icon
Mastercard
MA
+$142K

Sector Composition

Rank Sector Weight
1 Technology 19.8%
2 Healthcare 17.1%
3 Financials 11.02%
4 Industrials 10.79%
5 Consumer Staples 10.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XOM icon
51
ExxonMobil
XOM
$644B
$318K 0.54%
4,495
SJM icon
52
J.M. Smucker
SJM
$12.7B
$314K 0.53%
2,850
FTV icon
53
Fortive
FTV
$17.9B
$297K 0.5%
6,882
O icon
54
Realty Income
O
$59.6B
$268K 0.45%
3,612
UNP icon
55
Union Pacific
UNP
$174B
$263K 0.45%
1,626
AFL icon
56
Aflac
AFL
$64.9B
$262K 0.44%
5,000
MRK icon
57
Merck
MRK
$322B
$259K 0.44%
3,228
-105
-3% -$8.41K
AXP icon
58
American Express
AXP
$227B
$256K 0.43%
2,168
POR icon
59
Portland General Electric
POR
$5.8B
$254K 0.43%
4,500
NVO
60
Novo Nordisk
NVO
$208B
$246K 0.42%
9,500
STT icon
61
State Street
STT
$50.6B
$222K 0.38%
3,750
ORA icon
62
Ormat Technologies
ORA
$6B
$211K 0.36%
+2,840
New +$196K
ENTA icon
63
Enanta Pharmaceuticals
ENTA
$366M
-16,645
Closed -$1.41M
EOG icon
64
EOG Resources
EOG
$79.2B
-2,735
Closed -$254K
IPGP icon
65
IPG Photonics
IPGP
$3.61B
-1,430
Closed -$220K
ORCL icon
66
Oracle
ORCL
$374B
-4,250
Closed -$242K

Similar funds

Nancy B. Gardiner's Q3 2019 Portfolio in Review

As of Q3 2019, Nancy B. Gardiner held 71 positions worth $58.9M, down 3.8% from $61.3M the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Nancy B. Gardiner withdrew a net $2.49M in Q3 2019, closing 4 positions and reducing 34 holdings. Its most notable exit was Enanta Pharmaceuticals, an estimated $1.41M position sold in full.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Nancy B. Gardiner opened a new position in Ormat Technologies worth $211K.

  • Nancy B. Gardiner's largest Q3 2019 buy was Ormat Technologies: 2,840 shares worth $211K.
  • Nancy B. Gardiner added most to Becton Dickinson in Q3 2019, an estimated $347K increase.
  • Nancy B. Gardiner's biggest Q3 2019 reduction was Mastercard, cutting an estimated $142K.
  • Nancy B. Gardiner fully exited Enanta Pharmaceuticals in Q3 2019, selling an estimated $1.41M.
  • Nancy B. Gardiner's ten largest holdings make up 34% of its $58.9M portfolio in Q3 2019.
  • Nancy B. Gardiner opened 1 new position and closed 4 in Q3 2019.
  • Nancy B. Gardiner's portfolio value fell 3.8% quarter-over-quarter to $58.9M.

Based on Nancy B. Gardiner's 13F filing for Q3 2019, filed 6 Nov 2019.